search
Back to results

Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey

Primary Purpose

Breast Cancer

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Patient Reported Outcome Measure Survey result feedback
Sponsored by
University of Colorado, Denver
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Breast Cancer

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)FemaleDoes not accept healthy volunteers

We will target all patients with a new diagnosis of breast cancer who present to the breast multi-disciplinary clinic.

Inclusion:

  • Adult (18 years of age or more)
  • Female
  • Patients with breast cancer
  • Patients who can independently complete surveys

Exclusion

  • Age <18 years
  • Male
  • Patients who cannot independently complete surveys

Sites / Locations

  • University of Colorado HospitalRecruiting
  • Cherry Creek Medical Center
  • Lone Tree Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Experimental Group

Normative Control

Arm Description

Patients will receive the results from the PROM survey in graphical form each time they complete a survey.

These patients will complete the PROM surveys, but will not be presented with the results of the survey.

Outcomes

Primary Outcome Measures

BREAST Q patient satisfaction with breast surgeon domain
Patient satisfaction with patient-provider communication using the BREAST Q satisfaction with breast surgeon domain. The domain is scored from 0 to 100 points with more points representing higher patient satisfaction.

Secondary Outcome Measures

BREAST Q Patient reported outcome measure survey domains including: Satisfaction with breasts, psychosocial well being, physical well being, sexual well being, and effects of radiation domains.
Validated BREAST Q survey domains. All domains are scored 0 to 100 points. Higher points represent a better outcome. The subscales will not be used to create a total score.
Healthcare utilization including the use of social work services, psycho-oncology services, oncology fitness service, nutrition service, and urgent/emergent services including visits to urgent care or the emergency room.
The number of participants using supportive services will be scored as yes or no if the patient used the specific service or did not use the service.
Currently unmeasured patient reported outcomes using open ended questions
The investigators will use open ended questions to identify currently unmeasured patient reported outcomes. Responses will be evaluated as qualitative data using descriptive coding to identify themes. Expected common themes include financial concerns, concerns about caring for family or imposing on family, fertility concerns, etc. The questions will include: "what are your top 3 concerns", "what are you most worried about going forward", "how could the healthcare team better help you", "if you could start your treatment over what would you have done differently."

Full Information

First Posted
May 22, 2019
Last Updated
July 24, 2023
Sponsor
University of Colorado, Denver
Collaborators
National Cancer Institute (NCI)
search

1. Study Identification

Unique Protocol Identification Number
NCT03995082
Brief Title
Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey
Official Title
A Randomized Study of Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey Results
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Recruiting
Study Start Date
October 30, 2019 (Actual)
Primary Completion Date
June 2024 (Anticipated)
Study Completion Date
June 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Colorado, Denver
Collaborators
National Cancer Institute (NCI)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this research protocol is to measure Patient Reported Outcome Measures (PROMs) in breast cancer patients. PROM results will be provided to patients and providers and the investigators will evaluate the relationship between patient engagement with PROM results and patient and clinicopathologic variables, utilization of supportive and hospital services, and patient satisfaction with patient-provider communication.
Detailed Description
PROM Survey The BREAST-Q survey will be utilized to evaluate PROMs at the designated survey time points. The investigators will utilize the mastectomy and breast conserving therapy pre-operative and post-operative modules dependent on the type of surgery each patient chooses. The BREAST-Q survey has questions that pertain to the following domains: 1. Satisfaction with breasts, 2. Psychosocial well-being, 3. Physical well-being, 4. Sexual well-being, 5. Adverse effects of radiation, and 6. Patient experience with the health care team. Scores for each domain are scored with an equivalent Rasch transformed score (range 0-100). These scores can then be tracked over time. In addition to the BREAST-Q modules, the investigators will ask 3 open ended questions. These questions will allow patients to share concerns or outcomes at each time point in an effort to identify currently unmeasured outcomes that are important to patients. Timing of Surveys For patients having surgery first: At the pre-operative visit, patients will be provided the pre-operative module. The post-operative modules will then be administered via email or in the clinic at the post-operative visit (~2 weeks after surgery), and then at 3 months, 6 months, 9 months, and 12 months after surgery. After one year, patients will be surveyed annually. For patients receiving neoadjuvant chemotherapy, surveys will be administered every 3 months during the pre-operative period. The post-operative modules will then be administered via email or in the clinic at the post-operative visit (~2 weeks after surgery), and then at 3 months, 6 months, 9 months, and 12 months after surgery. After one year, patients will be surveyed annually. Patients will be randomized to receive the results of PROM surveys graphed over time (experimental group) or to not receive the results of the PROM surveys (normative control group). Results of the BREAST-Q surveys will be available to providers for all patients. Statistical Analyses Study data will be collected in a prospective database using the CCTSI RedCap database, with which the breast cancer program has extensive experience. The database will include demographic information, clinicopathologic data, surgical details, neoadjuvant and adjuvant treatments, and the equivalent Rasch transformed scores for each PROM metric at all recorded time points. Descriptive statistics will be utilized to characterize the patient population and patient engagement with PROMs. Univariate and multivariate analyses will be used to evaluate demographic and clinicopathologic variables and variations in PROMs across the course of treatment. The study endpoints will be evaluated with the following statistical methods:

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
370 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Experimental Group
Arm Type
Experimental
Arm Description
Patients will receive the results from the PROM survey in graphical form each time they complete a survey.
Arm Title
Normative Control
Arm Type
No Intervention
Arm Description
These patients will complete the PROM surveys, but will not be presented with the results of the survey.
Intervention Type
Other
Intervention Name(s)
Patient Reported Outcome Measure Survey result feedback
Intervention Description
Patients will receive a graph of their results from the PROM survey each time they complete a survey
Primary Outcome Measure Information:
Title
BREAST Q patient satisfaction with breast surgeon domain
Description
Patient satisfaction with patient-provider communication using the BREAST Q satisfaction with breast surgeon domain. The domain is scored from 0 to 100 points with more points representing higher patient satisfaction.
Time Frame
24 months
Secondary Outcome Measure Information:
Title
BREAST Q Patient reported outcome measure survey domains including: Satisfaction with breasts, psychosocial well being, physical well being, sexual well being, and effects of radiation domains.
Description
Validated BREAST Q survey domains. All domains are scored 0 to 100 points. Higher points represent a better outcome. The subscales will not be used to create a total score.
Time Frame
24 months
Title
Healthcare utilization including the use of social work services, psycho-oncology services, oncology fitness service, nutrition service, and urgent/emergent services including visits to urgent care or the emergency room.
Description
The number of participants using supportive services will be scored as yes or no if the patient used the specific service or did not use the service.
Time Frame
24 months
Title
Currently unmeasured patient reported outcomes using open ended questions
Description
The investigators will use open ended questions to identify currently unmeasured patient reported outcomes. Responses will be evaluated as qualitative data using descriptive coding to identify themes. Expected common themes include financial concerns, concerns about caring for family or imposing on family, fertility concerns, etc. The questions will include: "what are your top 3 concerns", "what are you most worried about going forward", "how could the healthcare team better help you", "if you could start your treatment over what would you have done differently."
Time Frame
24 months

10. Eligibility

Sex
Female
Accepts Healthy Volunteers
No
Eligibility Criteria
We will target all patients with a new diagnosis of breast cancer who present to the breast multi-disciplinary clinic. Inclusion: Adult (18 years of age or more) Female Patients with breast cancer Patients who can independently complete surveys Exclusion Age <18 years Male Patients who cannot independently complete surveys
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sarah Tevis
Phone
3037242731
Email
sarah.tevis@ucdenver.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sarah Tevis
Organizational Affiliation
University of Colorado, Denver
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Colorado Hospital
City
Denver
State/Province
Colorado
ZIP/Postal Code
80045
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sarah Tevis
Email
sarah.tevis@ucdenver.edu
First Name & Middle Initial & Last Name & Degree
Sarah Tevis
Facility Name
Cherry Creek Medical Center
City
Denver
State/Province
Colorado
ZIP/Postal Code
80206
Country
United States
Individual Site Status
Not yet recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sarah Tevis, MD
Phone
608-692-0836
Email
sarah.tevis@cuanschutz.edu
First Name & Middle Initial & Last Name & Degree
Sarah Tevis
Facility Name
Lone Tree Medical Center
City
Lone Tree
State/Province
Colorado
ZIP/Postal Code
80124
Country
United States
Individual Site Status
Not yet recruiting

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Breast Cancer Patient Engagement With Patient Reported Outcome Measure Survey

We'll reach out to this number within 24 hrs